feed,title,long_url,short_url
SeekingAlpha,Adverum Biotech doses first subject in phase 2 trial to treat wet AMD,https://seekingalpha.com/news/3882762,
SeekingAlpha,"ACV: Opportunity For The Long-Term, But Discount Tightens",https://seekingalpha.com/article/4540960,
